aberrations in cancer cells and targeted therapies shermaine mitchell july 27 2011 phd candidate
TRANSCRIPT
![Page 1: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/1.jpg)
Aberrations in Cancer Cells and Targeted Therapies
Shermaine Mitchell
July 27 2011
PhD Candidate
![Page 2: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/2.jpg)
Targeted therapy
Standard Chemo-therapy
Patient
![Page 3: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/3.jpg)
Normal cells vs. Cancer cells
![Page 4: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/4.jpg)
Cancer…what is it?
Uncontrolled growth of abnormal cells in the body
Benign and or pre-malignant tumors
ARE NOT CANCER A disease of the genome: Cancer is a
genetic disease1. Gain of function mutation
2. Loss of function mutations
3. Gene amplification
4. Overexpression
![Page 5: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/5.jpg)
How do cells receive instruction?
Cell growth/division Cell growth arrest Cell death
![Page 6: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/6.jpg)
Intracellular signaling
![Page 8: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/8.jpg)
Targeted Therapy
![Page 9: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/9.jpg)
![Page 10: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/10.jpg)
Growth factor signaling
![Page 11: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/11.jpg)
Overexpression of receptor
![Page 12: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/12.jpg)
Herceptin
![Page 13: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/13.jpg)
Mutations in Effector Molecules
![Page 14: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/14.jpg)
Lipidmodification for function
![Page 15: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/15.jpg)
![Page 16: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/16.jpg)
Loss of function mutation: evading apoptosis
![Page 17: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/17.jpg)
![Page 18: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/18.jpg)
Onyx -015
![Page 19: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/19.jpg)
Old Dog with New Tricks
![Page 20: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/20.jpg)
Ovarian Cancer
Most lethal gynecological cancer
65% of patients are diagnosed with stage III or stage IV disease
Recurring and resistant to treatment
21,880 new cases 13,850 deaths 85-90% of ovarian
cancers overexpress FRα20
No
rmal
Sta
ge
I
Sta
ge
II
Sta
ge
III
Sta
ge
IV
0.00001
0.0001
0.001
0.01
0.1
1
Rel
ativ
e F
R a
lph
a T
ran
scri
pts
Courtesy of Christina Cherian
Ovarian Cancer
![Page 21: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/21.jpg)
Mechanisms of Intracellular Folate Transport
21
• Predominant transporter of (anti)folates
Zhao R, Matherly LH, Goldman ID: Expert Rev. Mol. Med., 2009
PCFT=Proton-coupled folate transporterRFC=Reduced folate carrier
![Page 22: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/22.jpg)
Folates Essential water soluble B
vitamin Amino acid synthesis Essential for DNA
synthesis
a. Thymidylate (dTMP):TS
b. Purine nucleotides :
GARFT + AICARFT
Antifolates
Structural analogs of folic acid
Disrupt DNA synthesis Recognized by cellular
machinery used by folates
a. receptors
b. intracellular targets Inhibition of folate
dependent enzymes Nucleotide depletion
22
GARFT=Glycinamine Ribonucleotide formyl transferaseAICARFT= 5-Aminoimidozole 4-carboxamide ribonucleotide formyl transferaseTS= Thymidylate Synthase
![Page 23: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/23.jpg)
Normal vs. Cancer cells
Blood LumenBloodLumen
Normal Solid Tumors
RFC
vv
PCFT FRα23
![Page 24: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/24.jpg)
Antifolates
Aminopterin MTX Pemetrexed…
![Page 25: Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate](https://reader037.vdocuments.us/reader037/viewer/2022110322/56649d0c5503460f949e0528/html5/thumbnails/25.jpg)
Questions????